108 related articles for article (PubMed ID: 9723442)
1. In vitro biotransformation of SDZ RAD: a new immunosuppressive macrolide in human liver microsomal preparations.
Dannecker R; Vickers AE; Ubeaud G; Hauck C
Transplant Proc; 1998 Aug; 30(5):2206. PubMed ID: 9723442
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry.
Hallensleben K; Raida M; Habermehl G
J Am Soc Mass Spectrom; 2000 Jun; 11(6):516-25. PubMed ID: 10833025
[TBL] [Abstract][Full Text] [Related]
3. Structural elucidation by electrospray mass spectrometry: an approach to the in vitro metabolism of the macrolide immunosuppressant SDZ RAD.
Vidal C; Kirchner GI; Sewing KF
J Am Soc Mass Spectrom; 1998 Dec; 9(12):1267-74. PubMed ID: 9835072
[TBL] [Abstract][Full Text] [Related]
4. LC/ESI-MS allows simultaneous and specific quantification of SDZ RAD and cyclosporine, including groups of their metabolites in human blood.
Kirchner GI; Vidal C; Winkler M; Mueller L; Jacobsen W; Franzke A; Sewing KF
Ther Drug Monit; 1999 Feb; 21(1):116-22. PubMed ID: 10051064
[TBL] [Abstract][Full Text] [Related]
5. Isolation and identification of a C39 demethylated metabolite of rapamycin from pig liver microsomes and evaluation of its immunosuppressive activity.
Nickmilder MJ; Latinne D; De Houx JP; Verbeeck RK; Lhoëst GJ
Clin Chem; 1998 Mar; 44(3):532-8. PubMed ID: 9510858
[TBL] [Abstract][Full Text] [Related]
6. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
[TBL] [Abstract][Full Text] [Related]
7. Structural identification of three metabolites and a degradation product of the macrolide immunosuppressant sirolimus (rapamycin) by electrospray-MS/MS after incubation with human liver microsomes.
Streit F; Christians U; Schiebel HM; Meyer A; Sewing KF
Drug Metab Dispos; 1996 Nov; 24(11):1272-8. PubMed ID: 8937863
[TBL] [Abstract][Full Text] [Related]
8. In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry.
Lhoëst G; Hertsens R; Verbeeck RK; Maton N; Wallemacq P; Dehoux JP; Latinne D
J Mass Spectrom; 2001 Aug; 36(8):889-901. PubMed ID: 11523088
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
[TBL] [Abstract][Full Text] [Related]
10. Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin.
Christians U; Sattler M; Schiebel HM; Kruse C; Radeke HH; Linck A; Sewing KF
Drug Metab Dispos; 1992; 20(2):186-91. PubMed ID: 1352208
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.
Segarra I; Brazelton TR; Guterman N; Hausen B; Jacobsen W; Morris RE; Benet LZ; Christians U
J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):179-87. PubMed ID: 9892080
[TBL] [Abstract][Full Text] [Related]
12. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
Crowe A; Lemaire M
Pharm Res; 1998 Nov; 15(11):1666-72. PubMed ID: 9833985
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of sirolimus and its derivative everolimus by cytochrome P450 3A4: insights from docking, molecular dynamics, and quantum chemical calculations.
Kuhn B; Jacobsen W; Christians U; Benet LZ; Kollman PA
J Med Chem; 2001 Jun; 44(12):2027-34. PubMed ID: 11384247
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
[TBL] [Abstract][Full Text] [Related]
16. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
[TBL] [Abstract][Full Text] [Related]
17. Automated simultaneous quantification of the immunosuppressants 40-O-(2-hydroxyethyl) rapamycin and cyclosporine in blood with electrospray-mass spectrometric detection.
Vidal C; Kirchner GI; Wünsch G; Sewing KF
Clin Chem; 1998 Jun; 44(6 Pt 1):1275-82. PubMed ID: 9625053
[TBL] [Abstract][Full Text] [Related]
18. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of N-(5-chloro-2-methylphenyl)-N'-(2-methylpropyl)thiourea: species comparison and identification of a novel thiocarbamide-glutathione adduct.
Stevens GJ; Hitchcock K; Wang YK; Coppola GM; Versace RW; Chin JA; Shapiro M; Suwanrumpha S; Mangold BL
Chem Res Toxicol; 1997 Jul; 10(7):733-41. PubMed ID: 9250406
[TBL] [Abstract][Full Text] [Related]
20. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
